Manganese flux across the blood-brain barrier

Robert A Yokel1

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky Academic Medical Center, 511C Pharmacy Building, 725 Rose Street, Lexington, KY, 40536-0082, USA. ryokel@email.uky.edu

Neuromolecular Medicine
|November 11, 2009
PubMed

Insights

Manganese (Mn) enters the brain via carrier-mediated transport, not DMT-1. Its slow clearance and accumulation increase susceptibility to neurotoxicity from excess manganese exposure.

Area of Science:

  • Neuroscience
  • Toxicology
  • Biochemistry

Background:

  • Manganese (Mn) is vital for brain development and function.
  • Excessive manganese exposure poses a neurotoxic risk.
  • The chemical form of manganese influences its brain uptake and toxicity.

Purpose of the Study:

  • To elucidate the mechanisms of manganese transport into and out of the brain.
  • To investigate the role of specific transporters, like DMT-1, in brain manganese uptake.
  • To understand how manganese kinetics influence its neurotoxic potential.

Main Methods:

  • Investigated brain manganese influx in normal and DMT-1 deficient rats (Belgrade rats).
  • Assessed the dependence of manganese uptake on sodium, ATP, and mitochondrial inhibitors.
  • Examined manganese efflux rates using impermeable reference compounds.
  • Identified potential calcium-mediated transport mechanisms.

Main Results:

  • Brain manganese influx was not dependent on DMT-1, sodium, or ATP hydrolysis.
  • Mitochondrial energy inhibitors reduced brain manganese uptake.
  • Manganese and iron did not compete for brain uptake.
  • Brain manganese efflux was slower than diffusion-controlled processes, suggesting diffusion mediation.
  • Evidence suggests a store-operated calcium channel mediates manganese uptake, not a p-type ATPase.

Conclusions:

  • Brain manganese uptake is primarily carrier-mediated, potentially via store-operated calcium channels.
  • Brain manganese efflux is diffusion-mediated and slow.
  • The kinetics of manganese transport lead to accumulation with repeated exposure, increasing neurotoxicity risk.

Related Concept Videos

The Blood-brain Barrier00:49

The Blood-brain Barrier

Overview
Physiological Barriers01:25

Physiological Barriers

Physiological barriers are semi-permeable cellular structures restricting drug diffusion into intracellular compartments and tissues. There are six types of physiological barriers: blood endothelial, cell membrane, blood-brain, blood-cerebrospinal fluid (CSF), blood-placenta, and blood-testis barriers.
The blood endothelial barrier is the most porous of these. It allows all small ionized, un-ionized, and lipophilic molecules to pass through the endothelial lining into the interstitial space...
Transcellular Transport of Solutes01:23

Transcellular Transport of Solutes

Transcellular transport of solutes is the movement of substances like monosaccharides and amino acids through polarized cells. This transport mechanism is primarily seen in epithelial and endothelial cells aided by membrane transport proteins such as channels and transporters. The tight junctions between these cells confine the membrane proteins to the two sides of the cell. The epithelial cells have distinct apical and basolateral domains. In contrast, the endothelial cells show the luminal...
Microbes and Other Elemental Cycles01:24

Microbes and Other Elemental Cycles

Microbial activity plays a pivotal role in the biogeochemical cycling of iron and manganese, especially at the redox gradients characteristic of stratified aquatic environments. These cycles are driven by microbial transformations between oxidized and reduced forms of the metals, allowing organisms to exploit them for metabolic energy and structural purposes.Iron Cycling Across Redox GradientsIn neutral, oxygen-rich surface waters, iron is predominantly found in its oxidized, insoluble ferric...
Factors Affecting Drug Distribution: Physiological Barriers01:23

Factors Affecting Drug Distribution: Physiological Barriers

Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...